DR. MARTIN WELSCHOF

Commercial Advisory Member
Immunology and DNA sequencing expert
CEO – Bioinvent AB – A Public Immuno-Oncology Company
Board member of APIM Therapeutics AS, Nextera AS & Uni Targeting
Ph.D. Recombinant Antibody Technology, University of Heidelberg